NCT03699579View on ClinicalTrials.gov

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

February 22, 2019

Primary Completion Date

June 23, 2019

Study Completion Date

June 23, 2019

Conditions
Renal Cell Carcinoma MetastaticRenal Cell Carcinoma
Trial Locations (2)

100

National Taiwan University Hospital, Taipei

112

Taipei Veterans General Hospital, Taipei

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY

NCT03699579 - Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC | Biotech Hunter | Biotech Hunter